Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift

被引：0
|
作者：
Yun-Fan Liaw
机构：
[1] Chang Gung University College of Medicine,Liver Research Unit, Chang Gung Memorial Hospital
来源：
Hepatology International | 2019年 / 13卷
关键词：
Clinical relapse; Entecavir; Hepatitis flare; Hepatic decompenation; Sustained remission; Tenofovir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：665 / 673
页数：8
相关论文
共 50 条
  • [41] Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naive patients with chronic hepatitis B
    Wei, Lai
    Kao, Jia-Horng
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (03) : 495 - 504
  • [42] Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy
    Shang, Jin
    Liu, Huan
    Wen, Qin
    Ise, Rili M.
    Tu, You
    Bai, Lang
    Tang, Hong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 626 - 631
  • [43] Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis
    Koichi Honda
    Masataka Seike
    Kazunari Murakami
    World Journal of Hepatology, 2015, (22) : 2404 - 2410
  • [44] Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues
    Rapti, Irene
    Hadziyannis, Stephanos
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (08) : 1064 - 1073
  • [45] Telbivudine Versus Entecavir for Nucleos(t)ide-Naive HBeAg-Positive Chronic Hepatitis B: A Meta-analysis
    Liu, Hmin
    Wang, Xbo
    Wan, Gang
    Yang, Zyun
    Zeng, Hui
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (02) : 131 - 138
  • [46] Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy
    Franze, Maria Stella
    Saitta, Carlo
    Lombardo, Daniele
    Musolino, Cristina
    Caccamo, Gaia
    Filomia, Roberto
    Pitrone, Concetta
    Cacciola, Irene
    Pollicino, Teresa
    Raimondo, Giovanni
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (04)
  • [47] Antiviral effect of entecavir in nucleos(t)ide analogue-naive and nucleos(t)ide analogue- experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy
    Chen, Chien-Hung
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Lee, Chuan-Mo
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (08) : E55 - E64
  • [48] Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B
    Wu, Lina
    Lai, Jiadi
    Luo, Qiumin
    Zhang, Yeqiong
    Lin, Chaoshuang
    Xie, Dongying
    Chen, Youming
    Deng, Hong
    Gao, Zhiliang
    Peng, Liang
    Xu, Wenxiong
    LIVER RESEARCH, 2024, 8 (03) : 179 - 187
  • [49] Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
    Ridruejo, Ezequiel
    Silva, Marcelo O.
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (03) : 357 - 360
  • [50] Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B
    Zhang, N. -P.
    Reijnders, J. G. P.
    Perquin, M.
    Hansen, B. E.
    Janssen, H. L. A.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (07) : E252 - E257
12345